Hans J. Hansen

7.4k total citations · 1 hit paper
114 papers, 5.7k citations indexed

About

Hans J. Hansen is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Hans J. Hansen has authored 114 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Radiology, Nuclear Medicine and Imaging, 36 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Hans J. Hansen's work include Monoclonal and Polyclonal Antibodies Research (64 papers), Radiopharmaceutical Chemistry and Applications (54 papers) and Lymphoma Diagnosis and Treatment (15 papers). Hans J. Hansen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (64 papers), Radiopharmaceutical Chemistry and Applications (54 papers) and Lymphoma Diagnosis and Treatment (15 papers). Hans J. Hansen collaborates with scholars based in United States, Denmark and Switzerland. Hans J. Hansen's co-authors include David M. Goldenberg, Gary L. Griffiths, Rhona Stein, John Krupey, Paul Lo Gerfo, Serengulam V. Govindan, Rosalyn D. Blumenthal, Thomas M. Cardillo, Robert M. Sharkey and Ivan D. Horak and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Hans J. Hansen

113 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Demonstration of an Antigen Common to Several Varieties of Neoplasia

1971 388 citations Hans J. Hansen et al. profile →

Peers

Hans J. Hansen

RNMI

ONCOL

PFM

IMMUN

Mieczysław Gajda Germany

John N. Whitaker United States

Gail D. Lewis Phillips United States

Süleyman Ergün Germany

Dirk Winkler Germany

Harald Kropshofer Germany

Martin Trepel Germany

Karl G. Csaky United States

Sara M. Weis United States

Heribert Bohlen Germany

Mieczysław Gajda Germany

Hans J. Hansen

1.3k ×0.4

RNMI

899 ×0.5

ONCOL

1.1k ×0.7

596 ×0.5

PFM

504 ×0.5

IMMUN

Citations per year, relative to Hans J. Hansen Hans J. Hansen (= 1×) peers Mieczysław Gajda

Countries citing papers authored by Hans J. Hansen

Since Specialization

Citations

This map shows the geographic impact of Hans J. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J. Hansen more than expected).

Fields of papers citing papers by Hans J. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans J. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J. Hansen. The network helps show where Hans J. Hansen may publish in the future.

Co-authorship network of co-authors of Hans J. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans J. Hansen. A scholar is included among the top collaborators of Hans J. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans J. Hansen. Hans J. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brudek, Tomasz, Tove Christensen, Lars Aagaard, et al.. (2009). B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology. 6(1). 104–104. 86 indexed citations

Govindan, Serengulam V., Thomas M. Cardillo, Christopher D'Souza, et al.. (2007). Therapy of human colonic and lung cancer xenografts with SN-38 conjugates of anti-CEACAM5 and anti-EGP-1 humanized monoclonal antibodies. Molecular Cancer Therapeutics. 6. 3 indexed citations

Sapra, Puja, et al.. (2005). Construction, characterization, and mammalian expression of an immunotoxin consisting of ranpirnase (Rap) fused to a humanized anti-EGP-1 antibody, hRS7, as a potential therapeutic for prostate cancer. Cancer Research. 65. 160–160. 2 indexed citations

Qu, Zhengxing, Gary L. Griffiths, William A. Wegener, et al.. (2005). Development of humanized antibodies as cancer therapeutics. Methods. 36(1). 84–95. 40 indexed citations

Brudek, Tomasz, et al.. (2004). Simultaneous Presence of Endogenous Retrovirus and Herpes Virus Antigens Has Profound Effect on Cell-Mediated Immune Responses: Implications for Multiple Sclerosis. AIDS Research and Human Retroviruses. 20(4). 415–423. 33 indexed citations

Hansen, Hans J., Huaitian Liu, Mihail S. Iordanov, et al.. (2001). Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. Critical Reviews in Oncology/Hematology. 39(1-2). 79–86. 15 indexed citations

Stein, Rhona, Serengulam V. Govindan, Susan Chen, et al.. (2001). Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine. Critical Reviews in Oncology/Hematology. 39(1-2). 173–180. 12 indexed citations

Krishnan, Indira, et al.. (1999). Co-Secretion of Two Distinct Kappa Light Chains by the Mu-9 Hybridoma. Hybridoma. 18(4). 325–333. 3 indexed citations

Sharkey, Robert M., Thomas M. Behr, M. Jules Mattes, et al.. (1997). Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22. Cancer Immunology Immunotherapy. 44(3). 179–188. 70 indexed citations

10.

Karacay, Habibe, Robert M. Sharkey, Serengulam V. Govindan, et al.. (1997). Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Reagent Development. Bioconjugate Chemistry. 8(4). 585–594. 42 indexed citations

11.

Juweid, Malik E., Robert M. Sharkey, Thomas M. Behr, et al.. (1996). Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2. Cancer. 78(1). 157–168. 26 indexed citations

12.

Stein, Rhona, et al.. (1993). Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2. Cancer Immunology Immunotherapy. 37(5). 293–298. 67 indexed citations

13.

Sharkey, Robert M., Jeffry A. Siegel, George Y. Wong, et al.. (1993). Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14. Cancer. 71(6). 2082–2096. 55 indexed citations

14.

Griffiths, Gary L., et al.. (1992). Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Bioconjugate Chemistry. 3(2). 91–99. 52 indexed citations

15.

Goldenberg, David M., et al.. (1992). Microheterogeneity of a purified IgG1, due to asymmetric fab glycosylation. Molecular Immunology. 29(6). 751–758. 19 indexed citations

16.

Losman, Michele J., Marc Monestier, Hans J. Hansen, & David M. Goldenberg. (1990). Baboon anti‐idiotype antibodies mimic a carcinoembryonic antigen epitope. International Journal of Cancer. 46(2). 310–314. 14 indexed citations

17.

Goldenberg, David M., H Goldenberg, R M Sharkey, et al.. (1989). Imaging of colorectal carcinoma with radiolabeled antibodies. Seminars in Nuclear Medicine. 19(4). 262–281. 63 indexed citations

18.

Primus, F. James, et al.. (1977). Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen.. PubMed. 37(5). 1544–7. 49 indexed citations

19.

Primus, F. James, et al.. (1976). Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors.. PubMed. 36(7 PT 1). 2176–81. 13 indexed citations

20.

Coffey, Jacob W. & Hans J. Hansen. (1966). Sequential Synthesis of Two 7 S Lysins by Rats Challenged with Mouse Sarcoma-180 Tumor Cells. The Journal of Immunology. 96(6). 1021–1026. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact